Literature DB >> 21874061

Ustekinumab demonstrates activity in glucocorticoid-refractory acute GVHD.

J Pidala, L Perez, F Beato, C Anasetti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21874061     DOI： 10.1038/bmt.2011.172

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  16 in total

1.  CD4+ T cell STAT3 phosphorylation precedes acute GVHD, and subsequent Th17 tissue invasion correlates with GVHD severity and therapeutic response.

Authors:  Brian C Betts; Elizabeth M Sagatys; Anandharaman Veerapathran; Mark C Lloyd; Francisca Beato; Harshani R Lawrence; Binglin Yue; Jongphil Kim; Said M Sebti; Claudio Anasetti; Joseph Pidala
Journal:  J Leukoc Biol       Date:  2015-02-06       Impact factor: 4.962

2.  Essential Role of Interleukin-12/23p40 in the Development of Graft-versus-Host Disease in Mice.

Authors:  Yongxia Wu; David Bastian; Steven Schutt; Hung Nguyen; Jianing Fu; Jessica Heinrichs; Changqing Xia; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-04       Impact factor: 5.742

3.  IL-17A ≠ Th17 in GvHD.

Authors:  Yongxia Wu; Xue-Zhong Yu
Journal:  Cell Mol Immunol       Date:  2016-10-31       Impact factor: 11.530

Review 4.  Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation.

Authors:  Cameron McDonald-Hyman; Laurence A Turka; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2015-03-25       Impact factor: 17.956

Review 5.  Acute graft-versus-host disease: a bench-to-bedside update.

Authors:  Shernan G Holtan; Marcelo Pasquini; Daniel J Weisdorf
Journal:  Blood       Date:  2014-06-09       Impact factor: 22.113

Review 6.  Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.

Authors:  James Lm Ferrara; Christopher M Smith; Julia Sheets; Pavan Reddy; Jonathan S Serody
Journal:  J Clin Invest       Date:  2017-06-05       Impact factor: 14.808

7.  A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.

Authors:  Vivian Zhou; Kimberle Agle; Xiao Chen; Amy Beres; Richard Komorowski; Ludovic Belle; Carolyn Taylor; Fenlu Zhu; Dipica Haribhai; Calvin B Williams; James Verbsky; Wendy Blumenschein; Svetlana Sadekova; Eddie Bowman; Christie Ballantyne; Casey Weaver; David A Serody; Benjamin Vincent; Jonathan Serody; Daniel J Cua; William R Drobyski
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

8.  Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation.

Authors:  Brian C Betts; David Bastian; Supinya Iamsawat; Hung Nguyen; Jessica L Heinrichs; Yongxia Wu; Anusara Daenthanasanmak; Anandharaman Veerapathran; Alison O'Mahony; Kelly Walton; Jordan Reff; Pedro Horna; Elizabeth M Sagatys; Marie C Lee; Jack Singer; Ying-Jun Chang; Chen Liu; Joseph Pidala; Claudio Anasetti; Xue-Zhong Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-30       Impact factor: 11.205

Review 9.  Translational opportunities for targeting the Th17 axis in acute graft-vs.-host disease.

Authors:  F Malard; B Gaugler; B Lamarthee; M Mohty
Journal:  Mucosal Immunol       Date:  2016-01-27       Impact factor: 7.313

10.  CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates.

Authors:  Benjamin K Watkins; Victor Tkachev; Scott N Furlan; Daniel J Hunt; Kayla Betz; Alison Yu; Melanie Brown; Nicolas Poirier; Hengqi Betty Zheng; Agne Taraseviciute; Lucrezia Colonna; Caroline Mary; Gilles Blancho; Jean-Paul Soulillou; Angela Panoskaltsis-Mortari; Prachi Sharma; Anapatricia Garcia; Elizabeth Strobert; Kelly Hamby; Aneesah Garrett; Taylor Deane; Bruce R Blazar; Bernard Vanhove; Leslie S Kean
Journal:  J Clin Invest       Date:  2018-08-13       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.